Interpreting OCT

Article

Katherine M. Mastrota, OD, shares pearls from “Reading Between the Lines: CT Interpretation” lecture at the 90th annual SECO International meeting.

Associate Optometric Editor Katherine M. Mastrota, OD, shares pearls from “Reading Between the Lines: CT Interpretation” lecture at the 90th annual SECO International meeting in Atlanta:

Mohammad Rafieetary, OD, FAAO, at the Charles Retina Institute in Memphis, discussed the basic principals of OCT. OCT, in essence, is an optical biopsy of tissue, he said. The resolution of OCT images has become more refined with the development of spectral domain technology.

Focusing on the interpretation of OCT line studies, Dr. Rafieetary suggests viewing the monochrome (white-on-black or black-on-white) images as opposed to the color-assigned image. He pointed out that OCT can be utilized to evaluate areas throughout the retina, not only the macula and optic nerve head.

Dr. Rafieetary also reviewed posterior segment pathology from the vitreous through to the choroid in an excellent primer for OCT utilization in optometric practice.

Recent Videos
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Steve Ferrucci, OD, FAAO, discussed the detection and treatment of geographic atrophy during his AAOpt 2024 lecture, "Imaging Techniques and Emerging Therapies for Geographic Atrophy."
Raman Bhakhri, OD, FAAO, details AAOpt 2024 talks
Danica Marrelli, OD, FAAO, AAO Dip, talks OCT and glaucoma
Mark Dunbar, OD, FAAO, gives overview of advancements in GA treatment
Raman Bhakhri, OD, FAAO, overviews his talk on medications' potential side effects on the retina with Optometry Times
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
© 2024 MJH Life Sciences

All rights reserved.